ARCHIVES

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

This article is from The Cancer Letter archive.

Vol. 20 No. 04 | January 28, 1994

Download PDF Visit The Full Archive

Related Articles

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

March 5, 1993

O’Neill Recounts Private Meeting To Increase Cancer Appropriations

May 3, 1991

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

Mammography Had Limited Impact Among Swedish Women Age 40-69

July 27, 2012

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993

NCI Plans Program To Help Academics With Initial Stages of Drug Discovery.

November 30, 2007